(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

NEGEDIA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

NEGEDIA

ST13

US500000097257099

Class

42, 44

Filing

97257099

Registration

7000191

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

14

Latest update

01/23/2025

Trademark type

Word

Nice classes

42, 44

Filing date

02/08/2022

Registration date

03/14/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/14/2023

Last transaction

01/23/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

POZZUOLI (NA), IT

Examiner

BHANOT, KAPIL

Law office

L80

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

NEGEDIA S.R.L.
Next Generation Diagnostic Srl

Representatives

MICHAEL J. HYNAK HYNAK & ASSOCIATES, PC

Technical classification

Nice Classes

Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Scientific research for medical purposes in the field of genetic sciencegenetic engineeringrare diseasesoncology; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Consulting services in the field of biotechnology; Consulting services in the field of pharmaceutical research and development; Consulting services in the field of genetic science; Medical research in the field of oncology; Computer programming in the medical field; Development of new technology for others in the field of genomicsbiotechnologyDNA screening; Structural and functional analysis of genomes; Scientific and technological servicesresearch and design in the field of medical diagnostic equipment; Providing laboratory research services in the field of gene expressioncancer biology; Chemicalbiochemicalbiological and bacteriological research and analysis; Research and development in the pharmaceutical and biotechnology fields; Technical research in the field of pharmaceutical studies; Pharmaceutical research and development; Consulting services in the field of pharmacogenetics; Genetic mapping for scientific purposes; Genetic testing for scientific research purposes; Providing medical testing services and information in the field of cancer research and disease classification; Scientific and technological servicesscientific researchanalysistesting in the field of geneticsoncologyrare diseasesmolecular biology; Research and development of vaccines and medicines; Researchdevelopmentengineering and testing services in the fields of immunopharmaceuticals and vaccines; DNA screening for scientific research purposes; Providing an on-line searchable database in the field of geneticsrare diseases and oncology for scientific research purposes; Research and development services in the field of antibodies; Pharmaceutical product evaluation; Testing of pharmaceuticals; Laboratory research in the field of bacteriologychemistryphysicscytologygeneticssequencing; Bacteriological research and analysis; Scientific research for medical purposes in the field of geneticsrare diseasescancersequencingbiotechnology;

Class 44

Genetic testing for medical purposes; Performing diagnosis of diseases; Testing for medical diagnostic or treatment purposes in the field of infectious diseases; Medical screening services in the field of geneticsoncology and rare diseases; Providing medical information to medical professionals and research establishments in the form of reports in the field of rare diseasepharmaceutical-gene interactionsgeneticsoncology; DNA screening for medical purposes; Medical screening; Antibody testing for medical diagnostic or treatment purposes

Publications

History of USPTO decisions and trademark events.

14 publications found

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

01/22/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

03/14/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

03/14/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/27/2022

PUBO

PUBLISHED FOR OPPOSITION

12/27/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/07/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/22/2022

XAEC

EXAMINER'S AMENDMENT ENTERED

11/22/2022

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

11/22/2022

GNEA

EXAMINERS AMENDMENT E-MAILED

11/22/2022

CNEA

EXAMINERS AMENDMENT -WRITTEN

11/22/2022

DOCK

ASSIGNED TO EXAMINER

11/21/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/12/2022

NWAP

NEW APPLICATION ENTERED

02/11/2022

Continuous trademark protection

Get notified about every new filing that threatens NEGEDIA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.